HA
South Rampart Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| SRP-001 (Oral) | Acute & Chronic Pain, Neuropathy (Diabetic and Chemotherapy-induced) | Phase 2 |
| SRP-001 (IV) | Acute Post-Operative Pain | IND-Enabling |
| SRP-001 (Topical) | Ocular Pain | IND-Enabling |
Leadership Team at South Rampart Pharma
NB
Nicolas Bazan
Scientific Co-Founder
PM
Paul Mieyal
CBO
JB
Josh Blacher
CFO
CA
Craig Audet
Head, Regulatory Affairs
JM
John M. Wetzel
Director of Chemistry Manufacturing & Controls
RJ
Ron J. Christopher
Head of Clinical Pharmacology and Toxicology